Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2023-07-14 00:00:00 ET · period of report 2023-07-12 · accession 0001209191-23-042305 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-07-14 | 2023-07-12+ | RXRX | Burrell Terry-Ann | Dir | S - Sale | $12.07 | -117.0K | 69.5K | -63% | -$1.41M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-07-12 | S | D | 3,157 | $14.08 | 63,122 | D | — | — | (F5) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $13.81 to $14.56 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request. |
| 2 | Common | Class A Common Stock | 2023-07-13 | S | D | 8,275 | $12.59 | 54,847 | D | — | — | (F6) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $12.105 to $12.98 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request. |
| 3 | Common | Class A Common Stock | 2023-07-12 | S | D | 3,195 | $13.18 | 66,279 | D | — | — | (F4) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $12.76 to $13.72 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request. |
| 4 | Common | Class A Common Stock | 2023-07-12 | S | D | 24,302 | $11.25 | 147,545 | D | — | — | (F2) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $10.60 to $11.59 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request. |
| 5 | Common | Class A Common Stock | 2023-07-12 | S | D | 78,071 | $12.15 | 69,474 | D | — | — | (F3) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $11.60 to $12.54 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request. |